Proteins / LINGO3

DarkP0C6S8 · Homo sapiens (Human) · 592 aa

LINGO3

Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3

AI prediction, not experimentally verified. The function, GO terms and reasoning are generated by a model (BioReason-Pro). Treat them as a hypothesis to test, not as a fact.

Predicted 3D structure

AlphaFold model.

In plain language

LINGO3 has barely been studied. The model's best guess: A membrane-anchored extracellular adhesion receptor that uses a leucine-rich repeat scaffold capped by a cysteine-rich segment and followed by an immunoglobulin-like domain to mediate high-specificity protein binding at the cell surface. By assembling and stabilizing multiprotein complexes, it promotes the formation and maturation of synaptic junctions at the plasma membrane, where its modular ectodomain organizes presynaptic and postsynaptic machinery to drive synapse assembly.

Predicted function

A membrane-anchored extracellular adhesion receptor that uses a leucine-rich repeat scaffold capped by a cysteine-rich segment and followed by an immunoglobulin-like domain to mediate high-specificity protein binding at the cell surface.

Confidence: the model gives no confidence score, and this protein has no known function to compare with. Treat it as a hypothesis.

Sequence · 592 aa · coloured by model confidence
1MTCWLCVLSL11PLLLLPAAPP21PAGGCPARCE31CTVQTRAVAC41TRRRLTAVPD51GIPAETRLLE61LSRNRIRCLN71PGDLAALPAL81EELDLSENAI91AHVEPGAFAN101LPRLRVLRLR111GNQLKLIPPG121VFTRLDNLTL131LDLSENKLVI141LLDYTFQDLH151SLRRLEVGDN161DLVFVSRRAF171AGLLALEELT181LERCNLTALS191GESLGHLRSL201GALRLRHLAI211ASLEDQNFRR221LPGLLHLEID231NWPLLEEVAA241GSLRGLNLTS251LSVTHTNITA261VPAAALRHQA271HLTCLNLSHN281PISTVPRGSF291RDLVRLRELH301LAGALLAVVE311PQAFLGLRQI321RLLNLSNNLL331STLEESTFHS341VNTLETLRVD351GNPLACDCRL361LWIVQRRKTL371NFDGRLPACA381TPAEVRGDAL391RNLPDSVLFE401YFVCRKPKIR411ERRLQRVTAT421AGEDVRFLCR431AEGEPAPTVA441WVTPQHRPVT451ATSAGRARVL461PGGTLEIQDA471RPQDSGTYTC481VASNAGGNDT491YFATLTVRPE501PAANRTPGEA511HNETLAALRA521PLDLTTILVS531TAMGCITFLG541VVLFCFVLLF551VWSRGRGQHK561NNFSVEYSFR571KVDGPAAAAG581QGGARKFNMK591MI

Protein domains

Known building blocks found by InterPro, placed along the 592 amino acids of the chain. Hover or tap a block for details.

150100150200250300350400450500550592

Predicted function

Model summary

A membrane-anchored extracellular adhesion receptor that uses a leucine-rich repeat scaffold capped by a cysteine-rich segment and followed by an immunoglobulin-like domain to mediate high-specificity protein binding at the cell surface. By assembling and stabilizing multiprotein complexes, it promotes the formation and maturation of synaptic junctions at the plasma membrane, where its modular ectodomain organizes presynaptic and postsynaptic machinery to drive synapse assembly.

Predicted Gene Ontology terms

Molecular function

What it does chemically

Biological process

Which larger process it takes part in

  • GO:0051965 positive regulation of synapse assembly

Cellular component

Where in the cell it sits

Model reasoning

How the model got to its answer

  1. 01

    I begin by dissecting the domain architecture.

    The N-terminus carries IPR000372 (Leucine-rich repeat N-terminal domain, residues 24–58), which caps an extended LRR scaffold defined by IPR032675 (Leucine-rich repeat domain superfamily, residues 37–402). This LRR core is punctuated by multiple IPR003591/IRP001611 leucine-rich repeat units—typical subtypes spanning residues 77–100, 80–101, 101–124, 102–162, 125–148, 149–172, 173–196, and a mid-region cluster at 247–340—culminating in IPR000483 (Cysteine-rich flanking region, C-terminal, residues 352–405). This canonical LRRNT–LRR array–LRRCT arrangement creates a curved solenoid surface optimized for avid, shape-complementary protein binding. Immediately C-terminal to the LRR block lies an immunoglobulin module: IPR013783 (Immunoglobulin-like fold, residues 403–500), IPR036179 (Immunoglobulin-like domain superfamily, residues 403–501), IPR007110 (Immunoglobulin-like domain, residues 407–496), and IPR013098/IPR003599/IPR003598 (Ig I-set and subtype annotations, residues 412–497/414–498/420–487). The juxtaposition of an LRR solenoid with an Ig-like module is a hallmark of cell-adhesion and synaptic adhesion receptors that mediate high-specificity extracellular interactions. The overall architecture is captured by IPR050541 (Leucine-rich repeat and transmembrane domain-containing protein family, residues 158–505), which, despite its generic transmembrane annotation, here supports a membrane-anchored extracellular adhesion receptor.

  2. 02

    This architecture dictates molecular function.

    The LRRNT cap and cysteine-rich C-terminal flanking region stabilize a concave LRR surface that binds partner proteins with high affinity and selectivity, while the Ig-like domain provides an additional adhesive interface and rigidity. Together, these modules cause robust multivalent protein binding, aligning with GO:0005515 protein binding as the operative molecular function.

  3. 03

    From function to process, an extracellular LRR–Ig adhesion receptor at the cell surface is primed to organize synaptic contacts.

    The LRR solenoid commonly nucleates assembly of presynaptic and postsynaptic complexes, and the Ig-like domain refines specificity and spacing—mechanistically promoting the formation and stabilization of synaptic junctions. This causal chain supports GO:0051965 positive regulation of synapse assembly.

  4. 04

    Cellular location follows directly.

    The presence of a membrane-anchored extracellular LRR–Ig ectodomain and the family signature of membrane-associated LRR proteins place the protein at the cell surface. This supports a plasma membrane residence consistent with GO:0005886 plasma membrane and the stated membrane localization.

  5. 05

    Mechanistically, I hypothesize that the LRR array forms the principal ligand-binding platform that captures extracellular synaptic organizers, while the Ig-like domain stabilizes the complex and tunes intermembrane spacing.

    Likely partners include presynaptic organizers and postsynaptic adhesion systems that recognize LRR–Ig ectodomains. Candidate interactors include neurexins and neuroligins for trans-synaptic alignment, cerebellin–GluD complexes for inhibitory synapse specification, and receptor phosphatases such as LAR family members that couple adhesion to cytoskeletal remodeling. Through these assemblies, the receptor concentrates and stabilizes synaptic components at the plasma membrane, driving synapse assembly and maturation.

Technical details

InterPro entries

  • IPR032675 Leucine-rich repeat domain superfamily homologous superfamily · 37–402
  • IPR013783 Immunoglobulin-like fold homologous superfamily · 403–500
  • IPR036179 Immunoglobulin-like domain superfamily homologous superfamily · 403–501
  • IPR000372 Leucine-rich repeat N-terminal domain domain · 24–58
  • IPR000483 Cysteine-rich flanking region, C-terminal domain · 352–405
  • IPR007110 Immunoglobulin-like domain domain · 407–496
  • IPR013098 Immunoglobulin I-set domain · 412–497
  • IPR003599 Immunoglobulin domain subtype domain · 414–498
  • IPR003598 Immunoglobulin subtype 2 domain · 420–487
  • IPR050541 Leucine-rich repeat and transmembrane domain-containing protein family · 158–505
  • IPR003591 Leucine-rich repeat, typical subtype repeat · 77–100
  • IPR001611 Leucine-rich repeat repeat · 80–101
  • IPR003591 Leucine-rich repeat, typical subtype repeat · 101–124
  • IPR001611 Leucine-rich repeat repeat · 102–162
  • IPR003591 Leucine-rich repeat, typical subtype repeat · 125–148
  • IPR003591 Leucine-rich repeat, typical subtype repeat · 149–172
  • IPR003591 Leucine-rich repeat, typical subtype repeat · 173–196
  • IPR001611 Leucine-rich repeat repeat · 247–303
  • IPR003591 Leucine-rich repeat, typical subtype repeat · 247–268
  • IPR003591 Leucine-rich repeat, typical subtype repeat · 270–292
  • IPR003591 Leucine-rich repeat, typical subtype repeat · 293–316
  • IPR003591 Leucine-rich repeat, typical subtype repeat · 317–340
  • IPR001611 Leucine-rich repeat repeat · 319–340

Sources

Method

BioReason-Pro with the ESM3 protein language model (esm3-sm-open-v1). How the atlas is made →

API

/api/v1/proteins/P0C6S8 · API docs